Revealing PKPD & Dosing Regimens to Advance into the Clinic

Time: 2:30 pm
day: Day 1 PM - Stream B


*Remote Presentation 

  • Understanding PK/PD-efficacy relationship of targeted protein degraders is essential to translating degradation kinetics from preclinical to clinic
  • Mechanistic models of the data enable us to predict degradation and efficacious dosing regimens and effectively reduce clinical development timelines